PMC:7597510 / 1127-1254 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"T22","span":{"begin":68,"end":71},"obj":"Disease"},{"id":"T23","span":{"begin":96,"end":105},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":" events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies a"}

{"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":16,"end":25},"obj":"Disease"},{"id":"51","span":{"begin":96,"end":105},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:D007239"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" events such as infection and vaccination. Approximately 40%–70% of GBS cases develop following infection, and autoantibodies a"}